Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jessie H. Lu"'
Autor:
Emily A. Day, Logan K. Townsend, Sonia Rehal, Battsetseg Batchuluun, Dongdong Wang, Marisa R. Morrow, Rachel Lu, Lucie Lundenberg, Jessie H. Lu, Eric M. Desjardins, Tyler K.T. Smith, Amogelang R. Raphenya, Andrew G. McArthur, Morgan D. Fullerton, Gregory R. Steinberg
Publikováno v:
iScience, Vol 26, Iss 11, Pp 108269- (2023)
Summary: Atherosclerotic cardiovascular disease is characterized by both chronic low-grade inflammation and dyslipidemia. The AMP-activated protein kinase (AMPK) inhibits cholesterol synthesis and dampens inflammation but whether pharmacological acti
Externí odkaz:
https://doaj.org/article/3e71dfd38cb24b0fa08de9d413beeee1
Autor:
Jonathan D. Schertzer, Gregory R. Steinberg, Lucie Lundenberg, Alex E. Green, Jessie H. Lu, Rebecca J. Ford, Eric M. Desjardins, James S. V. Lally, Rachel Lu, Emily A. Day
Publikováno v:
The Biochemical journal. 477(12)
Sodium-glucose cotransporter 2 inhibitors such as canagliflozin lower blood glucose and reduce cardiovascular events in people with type 2 diabetes through mechanisms that are not fully understood. Canagliflozin has been shown to increase the activit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee727157746458878752970d107fa3cb
https://pubmed.ncbi.nlm.nih.gov/32510137
https://pubmed.ncbi.nlm.nih.gov/32510137
Autor:
Jessie H. Lu, James S. V. Lally, Jonathon D. Schertzer, Rachel Lu, Emily A. Day, Rebecca J. Ford, Gregory R. Steinberg
Publikováno v:
Atherosclerosis Supplements. 32:115
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::117b20e6daacb00c3364c5a34e42a532
https://doi.org/10.1016/j.atherosclerosissup.2018.04.354
https://doi.org/10.1016/j.atherosclerosissup.2018.04.354